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Diurnal variation in glomerular charge selectivity, urinary albumin
excretion and blood pressure in insulin-dependent diabetic patients. The
urinary albumin excretion rate (AER) in a subgroup of patients with
insulin-dependent diabetes mellitus (IDDM) steadily increases. In these
patients a concomitant reduction of the glomerular charge selectivity
index (SI) has been demonstrated. The aim of the present study was to
evaluate whether diurnal variation in AER could be related to a diurnal
variation in SI and/or a diurnal blood pressure variation. Thirty-three
patients with IDDM, 27 with normal albumin excretion (AER <20
iWmin; group D0) and six with incipient nephropathy (AER from 20 to
200 JLglmin; group DA), were studied. AER and SI (renal clearance ratio
of total-IgG/IgG4) were measured in three different urine collecting
periods: period A (8:00 am. to 12:00 am.), period B (12:00 a.m. to
bedtime) and period C (bedtime to 8:00 am.). A significant increase in SI
was seen during the nighttime: period A, 1.6 (0.2 to 3.8; mean, range);
period B, 1.7 (0.3 to 3.0); and period C, 2.0 (0.2 to 4.0); P = 0.01.
Corresponding to this observation, an overall significant decrease in AER
was found: period A, 10 (3 to 137) jzglmin (median, range); period B, 8 (3
to 84) zg/min; and period C, 5 (0 to 78) g/min; P < 0.001. In all three
sampling periods a negative correlation was found between AER and SI.
When group D0 was analyzed alone, the results were similar. Diurnal
variation in blood pressure was significantly positively correlated with
AER in group DA, but was not correlated to variation in AER in D0. We
suggest that in normoalbuminuric IDDM patients diurnal variation in
AER is related to diurnal variation in SI.
In patients with insulin-dependent diabetes mellitus (IDDM),
the cumulative incidence of diabetic nephropathy is approxi-
mately 30 to 40% [1]. In this subgroup of patients, their urinary
albumin excretion rate (AER) is steadily increasing. Additional
clinical or biochemical markers associated with the very earliest
pathophysiological events of diabetic nephropathy are needed to
clarify the nature of such a progressive leakiness of the urinary
filtration barrier.
So far, several studies have shown that in IDDM albuminuria is
associated to reduced amounts of the anionic molecule heparan
sulfate proteoglycan (HSPG) located within the extracellular
matrix [2—6]. The glomerular charge selectivity index (SI) ob-
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tamed by estimating the renal clearance of two molecules similarly
sized but differently charged, has been suggested to reflect the
glomerular charge, determined by the glomerular content of
HSPG [7]. It has been demonstrated that SI is significantly
reduced in patients with IDDM and albuminuria, even in the
subclinical range (AER < 200 g/min) [8, 9]. Moreover, SI has
recently been correlated to other well-known risk markers for
albuminuria such as poor metabolic control and glomerular
basement membrane thickness [10, 11]. Consequently, the calcu-
lated SI might be a candidate marker identifying IDDM patients
at risk for developing nephropathy.
However, if SI shall be of any clinical importance, we need to
gain further knowledge about the interrelationship between AER
and SI in patients with normoalbuminuria or incipient nephrop-
athy. So far a negative correlation between SI and AER in
patients with incipient nephropathy has been demonstrated [12].
The aim of the present study was to evaluate whether an expected
diurnal variation in AER could be related to a diurnal variation in
the glomerular charge selectivity index and/or a variation in
systemic blood pressure in patients with IDDM.
Methods
Patients
The study was designed as a cross-sectional cohort evaluation
with subgroup analysis, including IDDM patients with or without
albuminuria.
The patients were selected from the outpatient clinic at a
district hospital in The Netherlands. The protocol was approved
by the regional scientific ethical committee and the participants
gave informed consent. Forty-seven patients with IDDM were
enrolled in the study. They had an onset of diabetes before the age
of 40 years and required immediate treatment with insulin. Except
from insulin administrated by pens (80% of the patients had at
least 4 injections per day) the patients had no other medications.
The patients were either normoalbuminuric (AER < 20 g/min)
or had incipient nephropathy (AER in the range of 20 to 200
j.Lg/min). They had no history of non-diabetic renal disease. In two
patients urine samples were lost during transportation, and in 12
patients urinary IgG4 levels were below the detection level of our
assay, leaving 33 patients (27 normoalbuminurics in group D0 and
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Table 1. Baseline clinical and laboratory data in the total study population (N = 33) and in the subgroups D0 (N = 27) and DA (N = 6)
Sex
MIF
Age
years
Diabetes duration
years
Total-
glycohemoglobin
%
sBP dBP Creatinine clearance
mi/mmmm Hg
IDDM 18/15 38 15 7.2 131 80 120
(AER < 200 g/min) (18—64) (2—43) (3.2—12.1) (100—168) (58—108) (71—179)(N = 33)
Subgroups
IDDM (D0)
normoalbuminuric 14/13 38 13 75a 128 79 124
(AER <20 j.Lg/min) (18—64) (2—42) (4.2—12.1) (100—168) (58—108) (97—179)
IDDM (DA)
incipient nephropathy 4/2 40 21 55a 142 87 101
(AER 20—200 jsg/min) (24—62) (5—43) (3.2—6.7) (107—163) (68—96) (71—135)
Data are presented as mean (range).
a Normoalbuminuric patients vs patients with incipient nephropathy, P = 0.01
6 with incipient nephropathy in group DA) to be included in the
analysis. Further clinical data are given in Table 1.
Measurements
Blood samples including SIgG, SIgG4, total-glycohemoglobin and
serum creatinine (Se,) were taken in the morning. Thereafter
ambulatory 24-hour blood pressure measurement (AMBM) and
24-hour urine collection were started. The patient went home
doing ordinary daily activities avoiding excessive physical exercise.
The 24-hour urine was collected in three sampling periods:
morning-period (8:00 a.m. to 12:00 a.m.; period A), afternoon-
period (12:00 a.m. to bedtime; period B) and nighttime-period
(bedtime to 8:00 a.m.; period C). The subjects recorded their
sleeping hours. In each sampling period urinary IgG (Uigo),
urinary IgG4 (U1g04), AER, urinary creatinine (Ur), and urinary
retinol-binding protein (URBP) were measured. Sjg, SIgG4, UIgG
and UIgG4 were measured by ELISA [13]. Urine samples were
stored as previously described and assayed within 12 weeks from
sampling [13]. Within assay and day-to-day coefficient of varia-
tions were below 10%. SI was calculated as SI = (UIgG/SlgG)/(UIgG4/SIgG4), the subclass IgG4 being more anionic than total
IgG (IgG4, radius 55A, isoelectric point 5.5 to 6.0, vs. IgG, radius
55A, isoelectric point 5.8 to 7.3).
AER was determined using a nephelometric method (Beckman
Array analyzer) interassay variation 3.5%, lowest detection level
0.2 mg/liter. The average daytime-AER was calculated as AER
[g/min (period A)] X period A (mm) + AER [.Lg/min (period
B)] X period B (min)/{period A (mm) + period B (mm)], and the
percentage change in AER (-AER) as [(average daytime-AER
—
nighttime-AER)/(average daytime-AER)] x 100.
URBP, measured by ELISA method, had an interassay variation
from 1.2 to 3.1% and a day-to-day coefficient of variation from 9.2
to 10.5% [14]. Total-glycohemoglobin was measured by affinity
chromatography (Pierce columns; normal range 4.2 to 5.8%) and
serum and urinary creatinines were determined by Jaffe reaction
(Hitachi 717 automatic analyzer), and had an interassay variation
of 2.5%.
Noninvasive 24-hour ambulatory blood pressure was performed
using an automated device (Spacelabs 90207) which was pro-
grammed to measure systolic and diastolic blood pressures (sBP
and dBP) every 30 minutes from 0800 to 2200, and every 60
minutes from 2200 to 0800. Mean blood pressure (mBP) was
calculated. In addition to mean sBP and dBP also the percentage
change (-BP) from day to night was calculated as [(average
daytime-BP — average nighttime-BP)/(average daytime-BP)] X
100.
Statistics
Results are expressed as mean (range) except from AER and
URBP given as median (range). Differences between groups (D0
and DA) were assessed by the unpaired Mann-Whitney test.
Within groups, differences in AER, SI, SIgG, SIgG4, UIgG, UJgG4
and URBP in different sampling periods (A, B and C) were
assessed by paired Friedmann tests, and day-to-night differences
in systolic and diastolic blood pressures were evaluated using the
paired Wilcoxon test. Correlations were expressed by Pearson's
correlation coefficient, r, AER were logarithmically transformed.
P values <0.05 were accepted as significant. Data were processed
using the StatGraphics statistical software package (STSC Inc.,
Rockville, MD, USA).
Results
The median 24-hour AER in the 33 patients was 8 (2 to 90)
j.g/min (median, range): 6 (2 to 19) ig/min and 69 (27 to 90)
ig/min in groups D0 and DA, respectively. Apart from total
glycohemoglobin, mean age, diabetes duration, sBP, dBP and
clearance of creatinine were comparable between groups (Table
1).
During the 24-hour urinary collecting period a significant
diurnal variation in AER was found in the 33 patients, with the
lowest values at night (P < 0.001). In addition, a significant
difference in SI was seen with the highest values at night (P =
0.01, Table 2). Furthermore, a negative correlation between SI
and AER was found in each of the urinary collecting periods: r =
—0.54, P = 0.001 (period A), r = —0.75, P < 0.00001 (period B)
and r = —0.34, P = 0.06 (period C). When only looking at group
D0 similar results were obtained (Table 2). Within this group
URBP was measured in 16 patients. In these patients URBP
remained stable comparing the different sampling periods during
the 24 hours: period A, 69.5 (37 to 530) pg/liter (median, range);
period B, 71.5 (37 to 520) .tg/liter; and period C, 78.0 (33 to 1640)
g/1iter (P = 0.09). Although no diurnal difference in URBP was
found in this subgroup of patients a significant difference in SI (P
= 0.02) and AER (P < 0.001) was maintained.
Average 24 hour BPs during day and night and z-BP are given
in Table 2. The patients were mainly normotensive and blood
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N
Period A
(8.00 a.m.—
12.00 a.m.)
Period B
(12.00 p.m.—
bedtime)
Period C
(bedtime—
8.00 a.m.)
P
value
AER Total 33 10 (33—137) 8 (3—84) 5 (0—78) <0.001
1g/min
SI
sBP
D0
DA
Total
D0
DA
Total
27
6
33
27
6
33
7 (3—29)
95 (23—137)
1.6 (0.2—3.8)
1.8 (0.7—3.8)
1.0 (0.2—1.9)
133 (115—161)
6(3—21)
68 (40—84)
1.7 (0.3—3.0)
1.9 (0.8—3.0)
0.7 (0.3—1.0)
5 (0—18)
46 (14—78)
2.0 (0.2—4.0)
2.2 (0.7—4.0)
1.0 (0.2—1.7)
116 (97—153)
<0.001
0.03
0.01
0.002
0.85
<0.001
mm Hg
dBP Total 33 83 (72—101) 68 (54—90) <0.001
mm Hg
tsBP Total 33 12 (—9—39)
(%)
zdBP Total 33 18 (3—34)
(%)
pressures in groups D0 and DA were comparable. No correlation
between -BP and -AER was found neither in the combined
population or in group D0 separately (Fig. 1). However, in group
DA there was a significant positive correlation between these two
parameters (r = 0.87, P = 0.02, Fig. 1).
One patient, belonging to group D0, had an unexplained nightly
excretion of albumin vastly greater than the daily loss. Excluding
this patient from the study did not alter the results.
Discussion
The present study confirms previous results showing a signifi-
cant negative correlation between AER and SI in patients with
type 1 diabetes [121 In addition to the earlier study the present
data demonstrate that even within 24 hours, a diurnal variation of
AER seems to be associated to a diurnal variation in SI.
What are the physiological mechanism causing this diurnal
variation in SI? It has been shown that changes in renal blood flow
alter the fractional distribution of blood flow between the inner
and outer cortex [15]. Furthermore, it has been suggested, that
qualitative differences exist in permeability between the glomeruli
in the inner and outer renal cortex [16]. Thus, an interglomerular
unequal distribution of anionic molecules could explain that a
diurnal variation in SI might be influenced by a shift in the
population of perfused glomeruli. Another explanation for a
diurnal variation in SI could be physiological day and night
pressure alterations within the kidney tissue, that is, pressure
reduction during nighttime might influence the morphology of the
glomerular basement membrane. At a relaxed stage the basement
membrane may contract, thus presenting an increasing amount of
anionic charge (HSPG) per area filtration surface. During night
this could account for the concomitant reduction in AER and in
increment in SI, demonstrated in the present study.
Altered tubular charge may influence the excretion level of
urinary albumin, -IgG, and -IgG4. Although we were only able to
measure URBP in 16 out of 27 normoalbuminuric diabetic pa-
tients, we found no diurnal variation in URBP. Unaltered diurnal
URBP in normoalbuminuric patients with IDDM has recently
been confirmed by others [17]. Furthermore, earlier studies have
demonstrated that in patients with IDDM, tubular function is well
preserved until advanced diabetic nephropathy occurs [7, 18].
Thus, in our group of patients it is unlikely that altered tubular
charge influence our results.
It was emphasized that during the 24-hour study period the
patients should continue their ordinary daily activities, and thus
blood samples for SlaG and 5IgG4 were not taken during the urine
sampling periods. The SI calculations are therefore all made on
the basis of morning 51g0 and SIgG4 levels. Only few studies
concerning diurnal variations of and 5IgG4 have been pub-
lished. In patients with rheumatoid arthritis circulating immune
complexes showed a circadian variation presumably related to
variations in subjective clinical assessment of illness [19]. Except
for having diabetes all our patients were healthy and we did not
find any significant day-to-day variation in and 5JgG4 levels.
We find no reasons to believe that a diurnal variation of the
and 5IgG4 levels should be of major importance for our results.
Due to a U1g04 excretion below the detection level of our assay,
twelve patients (11 being normoalbuminuric and 1 with incipient
nephropathy) were excluded from the study. Whether this loss of
patients influences the results remains unknown. Meanwhile, in
five out of the twelve patients (4 being normoalbuminuric and 1
having incipient nephropathy) UIgG4 measurements were only
missing from the nighttime period. Including these patients in the
study (N = 38), estimating the missing U1504 level to 8 pg/liter(the detection level of the assay) corresponding to the lowest
possible nighttime SI, the diurnal variation in SI remained signif-
icant with the highest values at night (P = 0.03), supporting our
presented data.
The positive correlation between diurnal variation in blood
pressure and AER among the six patients with albuminuria has
recently been confirmed by others [17]. The prognostic implica-
tions of abnormal diurnal variations in blood pressure are not fully
established yet, but it could be an additional marker for the
Table 2. Diurnal variation in AER, SI and blood pressure in the total
study population and in the subgroups D0 and DA
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Fig. 1. Correlation between diurnal variation in blood pressure (L1-mBP)
and diurnal variation in urinary albumin excretion rate (z-AER). The
correlation was significant in patients with incipient nephropathy (group
DA, A; r = 0.87, P = 0.02). In normoalbuminuric patients (group D0, +)
no significant correlation was found (r =0.20, P = 0.32).
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progression of albuminuria. Thus, diurnal variation in AER in
patients with incipient nephropathy seems to be associated with
diurnal variations in blood pressure and not to or only to a minor
degree to variations in SI. Whether diurnal variation in blood
glucose influence this result remains unanswered.
We suggest that in normoalbuminuric patients with IDDM, the
diurnal variation in 24 hour AER is related to a diurnal variations
in SI and not to variations in BP.
Reprint requests to Dr. Pernille MØrk Hansen, Steno Diabetes Center, Niels
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